ESMO

ESMO 2024 Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments Donwload Press release (PDF) Donwload the Poster (PDF)

Presentation

Transgene in a nutshell Download(PDF)   Corporate Presentation Download(PDF)   Universal Registration Document Download(PDF)

Transgene sa
400 Boulevard Gonthier d’Andernach - Parc d'Innovation - CS80166
67405 Illkirch Graffenstaden Cedex - France |
Tel. : + 33 (0) 3 88 27 91 00

 

© 2023 Transgene - All rights reserved
Credits